provider services
Boehringer Ingelheim Pharmaceuticals — product information and adverse-reaction reporting
BI product information and suspected adverse-reaction reporting
Published hoursNot published in this record
Confirm the exact product or service
National contact — confirm product and location
Not researched for this route
JARDIANCE U.S. prescribing information directs suspected adverse-reaction reports to Boehringer Ingelheim Pharmaceuticals, Inc. at this number, and the Medication Guide lists it for more information about JARDIANCE. Use for BI product information/safety questions; not the CareConnect4Me hub or savings-card line. BI's medical information website blocked automated retrieval, so hours/TTY were not captured.
View source ↗ · Source checked 2026-10-24
Report an update